Stock Events

Stock Events

Chugai Pharmaceutical 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24AprExpected
Q4 2025
Next
0.35
0.37
0.39
0.42
Expected EPS
0.3517282931054464
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CUP.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc. competes in various therapeutic areas including oncology, vaccines, and immunology, similar to Chugai's focus areas.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a direct competitor in the oncology and immunology sectors, areas where Chugai is actively developing treatments.
Novartis
NVS
Mkt Cap297.32B
Novartis AG operates in the same therapeutic areas as Chugai, including oncology and rheumatology, making it a strong competitor.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the oncology, immunology, and neuroscience sectors.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca PLC has a strong presence in oncology, respiratory, and cardiovascular diseases, competing with Chugai's research and drug portfolio.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb Company competes in the oncology sector, particularly in developing treatments for cancer, a key area for Chugai.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline plc competes with Chugai in the areas of oncology and immunology, with a focus on developing innovative medicines and vaccines.
Sanofi
SNY
Mkt Cap116.63B
Sanofi competes across several of the same therapeutic areas as Chugai, including oncology, immunology, and rare diseases.
Takeda Pharmaceutical
TAK
Mkt Cap59.2B
Takeda Pharmaceutical Company Limited, as a major Japanese pharmaceutical, competes directly with Chugai in the domestic market across various therapeutic areas including oncology and gastroenterology.

About

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
Show more...
CEO
Dr. Osamu Okuda
Employees
5026
Country
United States
ISIN
JP3519400000

Listings

MX
MX
4519N.MX
STU
DE
CUP.STU
MU
DE
CUP.MU
MU
DE
CUP0.MU

0 Comments

Share your thoughts

FAQ

What is Chugai Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chugai Pharmaceutical stocks are traded under the ticker CUP.MU.
When is the next Chugai Pharmaceutical earnings date?▼
Chugai Pharmaceutical is going to release the next earnings report on April 24, 2026.
What were Chugai Pharmaceutical earnings last quarter?▼
CUP.MU earnings for the last quarter are 0.42 EUR per share, whereas the estimation was 0.39 EUR resulting in a +5.48% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Chugai Pharmaceutical have?▼
As of April 12, 2026, the company has 5,026 employees.
In which sector is Chugai Pharmaceutical located?▼
Chugai Pharmaceutical operates in the Health & Wellness sector.
When did Chugai Pharmaceutical complete a stock split?▼
Chugai Pharmaceutical has not had any recent stock splits.
Where is Chugai Pharmaceutical headquartered?▼
Chugai Pharmaceutical is headquartered in Chuo, United States.